WHO Prequalifies First Vaccine Against Mpox
The World Health Organization (WHO) has added the MVA-BN vaccine to its prequalification list as the first approved vaccine for mpox. This prequalification aims to […]
Skip to content
You May Also Like:
Russia Develops Free Cancer Vaccine: A New Era in Global Healthcare
In a landmark medical breakthrough, Russia has announced the development of a cancer vaccine that will be distributed free of cost. This initiative marks a […]
Pharma Giants Collaborate to Revolutionize Biotech Manufacturing
In an exciting development for the pharmaceutical and biotech sectors, two of the world’s leading pharmaceutical companies have announced a groundbreaking partnership to ramp up […]
Indigenous Gene Therapy for Hemophilia A Shows Promising Results in Human Trials
A revolutionary indigenous gene therapy for Hemophilia A, a rare blood disorder, has recently delivered significant positive results in its first human trials. This breakthrough […]
£16 Million Investment to Strengthen UK-Switzerland Life Sciences Research
The United Kingdom and Switzerland have unveiled a major investment in life sciences research, committing a combined £16 million to foster innovation in healthcare and […]
New Immunotherapy Shows Early Promise in Treating Breast Cancer
A novel immunotherapy for breast cancer is showing significant early results in clinical trials, offering new hope for patients with advanced forms of the disease. […]
Enhancing Antibiotic Stability with Advanced Coating Technology
A groundbreaking new coating process is addressing one of the most persistent challenges in the pharmaceutical industry: preserving the stability and efficacy of antibiotics. Specifically, […]